Genascence Announces Six-Month Results from Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms ...Middle East

Mean IL-1Ra expression reached and maintained target levels in synovial fluid throughout six-month follow-up period Immune-conditioning with short steroid course supported higher levels of transgene expression Results will guide design of Phase 2 study and discussion with regulatory...

Read More Details
Finally We wish PressBee provided you with enough information of ( Genascence Announces Six-Month Results from Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms )

Also on site :

• Greece probes Azerbaijani arrested for espionage for links to Iran
• Music Icon's Rarely Seen Daughter, 77, Photographed in Los Angeles
• Shipping giant Maersk divests from companies linked to Israeli settlements